These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1102516

  • 1. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.
    Grüneberg RN.
    J Antimicrob Chemother; 1975 Sep; 1(3):305-10. PubMed ID: 1102516
    [No Abstract] [Full Text] [Related]

  • 2. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K, Korner B.
    Chemotherapy; 1974 Sep; 20(2):97-101. PubMed ID: 4210895
    [No Abstract] [Full Text] [Related]

  • 3. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R, Koch UJ.
    Chemotherapy; 1973 Sep; 18(4):242-52. PubMed ID: 4571975
    [No Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of sulphonamide and co-trimoxazole.
    Lacey RW, Anderson JD, Lewis EL, Gillespie WA.
    Lancet; 1973 Sep 01; 2(7827):509. PubMed ID: 4125033
    [No Abstract] [Full Text] [Related]

  • 5. Resistance to co-trimoxazole.
    McAllister TA.
    Scand J Infect Dis Suppl; 1976 Sep 01; (8):29-38. PubMed ID: 1084551
    [No Abstract] [Full Text] [Related]

  • 6. [Combination of trimethoprim and sulfamethoxazole in coliform urinary infections].
    Langlois Y, Mélançon J, Tétreault L.
    Union Med Can; 1973 Feb 01; 102(2):395-9. PubMed ID: 4575499
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of sulphonamide and co-trimoxazole in urinary-tract infections in Ceylon.
    Senewiratne B, Hettiarachchi J, Senewiratne K.
    Lancet; 1973 Aug 04; 2(7823):225-7. PubMed ID: 4124419
    [No Abstract] [Full Text] [Related]

  • 11. [The bioavailability and clinical efficay of drylin, a new drug combination of TMP/SMZ].
    Rilling GJ.
    Fortschr Med; 1977 Sep 22; 95(25):2167-70. PubMed ID: 410716
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo.
    Acar JF, Goldstein F, Chabbert YA.
    J Infect Dis; 1973 Nov 22; 128():Suppl:470-7 p. PubMed ID: 4585953
    [No Abstract] [Full Text] [Related]

  • 13. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.
    Anderson JD, Lacey RW, Lewis EL, Sellin MA.
    J Clin Pathol; 1974 Aug 22; 27(8):619-22. PubMed ID: 4425219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD, Freeman A, Foxman B.
    Clin Infect Dis; 2002 Apr 15; 34(8):1061-6. PubMed ID: 11914994
    [Abstract] [Full Text] [Related]

  • 19. Do sulphonamide-trimethoprim combinations select less resistance to trimethoprim than the use of trimethoprim alone?
    Lacey RW.
    J Med Microbiol; 1982 Nov 15; 15(4):403-27. PubMed ID: 6294297
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.